Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breathing Exercises | 1 | 2021 | 21 | 0.820 |
Why?
|
| Respiration Disorders | 1 | 2021 | 45 | 0.810 |
Why?
|
| Sleep Disorders, Circadian Rhythm | 1 | 2021 | 16 | 0.800 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2018 | 82 | 0.710 |
Why?
|
| Dyspnea | 3 | 2017 | 416 | 0.620 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2016 | 228 | 0.520 |
Why?
|
| Iatrogenic Disease | 1 | 2016 | 183 | 0.520 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 82 | 0.520 |
Why?
|
| Respiration | 1 | 2017 | 447 | 0.500 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 1946 | 0.440 |
Why?
|
| Respiratory Function Tests | 3 | 2021 | 318 | 0.400 |
Why?
|
| Lung | 4 | 2023 | 3151 | 0.400 |
Why?
|
| Pleural Effusion, Malignant | 3 | 2019 | 156 | 0.390 |
Why?
|
| Disorders of Excessive Somnolence | 2 | 2021 | 35 | 0.380 |
Why?
|
| Analgesics, Opioid | 2 | 2017 | 1371 | 0.380 |
Why?
|
| Neoplasms | 8 | 2023 | 15193 | 0.330 |
Why?
|
| Pain | 1 | 2017 | 1658 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 3976 | 0.320 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 1021 | 0.320 |
Why?
|
| Sleep | 5 | 2022 | 413 | 0.300 |
Why?
|
| Sleep Wake Disorders | 3 | 2021 | 348 | 0.270 |
Why?
|
| Clinical Decision-Making | 2 | 2021 | 524 | 0.270 |
Why?
|
| Thoracentesis | 3 | 2020 | 59 | 0.230 |
Why?
|
| Ecological Momentary Assessment | 1 | 2022 | 21 | 0.220 |
Why?
|
| Polysomnography | 3 | 2021 | 155 | 0.210 |
Why?
|
| Respiratory Muscles | 1 | 2021 | 27 | 0.210 |
Why?
|
| Inhalation | 1 | 2021 | 42 | 0.210 |
Why?
|
| Fitness Trackers | 1 | 2021 | 22 | 0.200 |
Why?
|
| Vital Capacity | 1 | 2021 | 131 | 0.190 |
Why?
|
| Diaphragm | 1 | 2021 | 181 | 0.190 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 254 | 0.180 |
Why?
|
| Exercise | 3 | 2022 | 1183 | 0.180 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 314 | 0.180 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 105 | 0.170 |
Why?
|
| Pneumothorax | 1 | 2020 | 153 | 0.170 |
Why?
|
| Feasibility Studies | 2 | 2021 | 2292 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2021 | 267 | 0.170 |
Why?
|
| Pleural Effusion | 1 | 2020 | 201 | 0.170 |
Why?
|
| Mexican Americans | 1 | 2021 | 322 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 538 | 0.160 |
Why?
|
| Tracheostomy | 1 | 2021 | 243 | 0.160 |
Why?
|
| Respiratory Insufficiency | 1 | 2021 | 330 | 0.150 |
Why?
|
| Blood Loss, Surgical | 1 | 2019 | 309 | 0.150 |
Why?
|
| Hydrothorax | 1 | 2017 | 18 | 0.150 |
Why?
|
| Pilot Projects | 2 | 2021 | 2803 | 0.150 |
Why?
|
| Cryptococcosis | 1 | 2017 | 63 | 0.150 |
Why?
|
| Pleurodesis | 1 | 2017 | 71 | 0.150 |
Why?
|
| Catheters, Indwelling | 2 | 2017 | 374 | 0.150 |
Why?
|
| Lung Diseases, Fungal | 1 | 2017 | 124 | 0.140 |
Why?
|
| Tongue Neoplasms | 1 | 2018 | 246 | 0.140 |
Why?
|
| Middle Aged | 17 | 2021 | 86204 | 0.140 |
Why?
|
| Fentanyl | 1 | 2017 | 148 | 0.140 |
Why?
|
| Pleura | 1 | 2017 | 127 | 0.140 |
Why?
|
| Bronchoscopy | 1 | 2019 | 474 | 0.140 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2017 | 123 | 0.140 |
Why?
|
| Hemothorax | 1 | 2015 | 20 | 0.140 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 95 | 0.130 |
Why?
|
| Humans | 28 | 2023 | 261506 | 0.130 |
Why?
|
| Disease Management | 1 | 2021 | 1052 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2023 | 12873 | 0.130 |
Why?
|
| Pneumonia | 1 | 2021 | 751 | 0.130 |
Why?
|
| Thrombocytopenia | 1 | 2019 | 846 | 0.120 |
Why?
|
| Health Behavior | 1 | 2019 | 603 | 0.120 |
Why?
|
| Esophageal Fistula | 1 | 2014 | 27 | 0.120 |
Why?
|
| Respiratory Tract Fistula | 1 | 2014 | 33 | 0.120 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2017 | 833 | 0.120 |
Why?
|
| Treatment Outcome | 5 | 2021 | 32848 | 0.120 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2014 | 67 | 0.120 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 226 | 0.110 |
Why?
|
| Female | 17 | 2022 | 141928 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 3869 | 0.110 |
Why?
|
| Algorithms | 2 | 2021 | 3890 | 0.100 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2017 | 713 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 4744 | 0.100 |
Why?
|
| Pneumonectomy | 1 | 2017 | 831 | 0.100 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 8865 | 0.100 |
Why?
|
| Drainage | 3 | 2020 | 416 | 0.100 |
Why?
|
| Male | 16 | 2021 | 123000 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1362 | 0.090 |
Why?
|
| Adult | 13 | 2023 | 77950 | 0.090 |
Why?
|
| Risk Factors | 5 | 2019 | 17523 | 0.090 |
Why?
|
| Obesity | 2 | 2021 | 2884 | 0.090 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 661 | 0.090 |
Why?
|
| Anemia | 1 | 2015 | 689 | 0.090 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.090 |
Why?
|
| Patient Selection | 1 | 2017 | 2055 | 0.090 |
Why?
|
| Retrospective Studies | 9 | 2023 | 37905 | 0.080 |
Why?
|
| Leukosialin | 1 | 2008 | 16 | 0.080 |
Why?
|
| Sarcoma | 2 | 2017 | 1725 | 0.080 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2009 | 135 | 0.080 |
Why?
|
| Parathyroidectomy | 1 | 2009 | 203 | 0.080 |
Why?
|
| Aged | 12 | 2021 | 70117 | 0.080 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 2979 | 0.080 |
Why?
|
| Fatigue | 3 | 2021 | 1239 | 0.080 |
Why?
|
| Th2 Cells | 1 | 2008 | 257 | 0.070 |
Why?
|
| Self Report | 2 | 2022 | 756 | 0.070 |
Why?
|
| Th1 Cells | 1 | 2008 | 250 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2014 | 1248 | 0.070 |
Why?
|
| Hematologic Neoplasms | 1 | 2017 | 1870 | 0.070 |
Why?
|
| Aged, 80 and over | 7 | 2021 | 29902 | 0.070 |
Why?
|
| fas Receptor | 1 | 2006 | 185 | 0.060 |
Why?
|
| Eosinophils | 1 | 2006 | 162 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 582 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2017 | 6869 | 0.060 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2023 | 53 | 0.060 |
Why?
|
| Radiography, Thoracic | 2 | 2017 | 462 | 0.060 |
Why?
|
| Nasopharynx | 1 | 2023 | 119 | 0.060 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 1866 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2018 | 5437 | 0.050 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2017 | 4757 | 0.050 |
Why?
|
| Aftercare | 1 | 2023 | 259 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 9244 | 0.050 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2021 | 6915 | 0.050 |
Why?
|
| Inflammation | 2 | 2008 | 2522 | 0.050 |
Why?
|
| Suction | 1 | 2020 | 104 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2017 | 1863 | 0.040 |
Why?
|
| Young Adult | 4 | 2020 | 21445 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 156 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2023 | 661 | 0.040 |
Why?
|
| Asthma | 1 | 2006 | 871 | 0.040 |
Why?
|
| Administration, Buccal | 1 | 2017 | 5 | 0.040 |
Why?
|
| Walk Test | 1 | 2017 | 43 | 0.040 |
Why?
|
| Maintenance Chemotherapy | 1 | 2017 | 202 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 7551 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2021 | 1681 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 59536 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2022 | 1000 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 611 | 0.030 |
Why?
|
| Texas | 2 | 2017 | 6311 | 0.030 |
Why?
|
| Pleural Cavity | 1 | 2014 | 25 | 0.030 |
Why?
|
| Adenine | 1 | 2017 | 631 | 0.030 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2014 | 87 | 0.030 |
Why?
|
| Time Factors | 3 | 2019 | 12926 | 0.030 |
Why?
|
| Hospitalization | 1 | 2023 | 2083 | 0.030 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2014 | 80 | 0.030 |
Why?
|
| Adolescent | 3 | 2020 | 31252 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 698 | 0.030 |
Why?
|
| Drugs, Investigational | 1 | 2014 | 135 | 0.030 |
Why?
|
| Survivors | 1 | 2018 | 1031 | 0.030 |
Why?
|
| Neck Dissection | 1 | 2014 | 290 | 0.030 |
Why?
|
| Piperidines | 1 | 2017 | 1035 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2015 | 583 | 0.030 |
Why?
|
| Anilides | 1 | 2014 | 268 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2014 | 829 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 2588 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1249 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2019 | 2203 | 0.020 |
Why?
|
| Thyroidectomy | 1 | 2014 | 486 | 0.020 |
Why?
|
| Diet | 1 | 2019 | 1440 | 0.020 |
Why?
|
| Comorbidity | 1 | 2017 | 2352 | 0.020 |
Why?
|
| Quinolines | 1 | 2014 | 383 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 672 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2014 | 580 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2017 | 5542 | 0.020 |
Why?
|
| Pyrroles | 1 | 2014 | 576 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 5673 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 4314 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 1471 | 0.020 |
Why?
|
| Parathyroid Hormone | 1 | 2009 | 194 | 0.020 |
Why?
|
| Interleukin-5 | 1 | 2008 | 73 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 1009 | 0.020 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2008 | 51 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 163 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 1 | 2008 | 146 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2008 | 284 | 0.020 |
Why?
|
| Logistic Models | 1 | 2014 | 3441 | 0.020 |
Why?
|
| Pyridines | 1 | 2014 | 1244 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 634 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2008 | 263 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2008 | 905 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2017 | 9180 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 1178 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2017 | 3518 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6207 | 0.020 |
Why?
|
| Eosinophilia | 1 | 2006 | 176 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2006 | 446 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2009 | 786 | 0.010 |
Why?
|
| United States | 1 | 2021 | 15433 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2008 | 1620 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2017 | 13658 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2006 | 1144 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 1537 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 1146 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 12221 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 1819 | 0.010 |
Why?
|
| Quality of Life | 1 | 2014 | 4532 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2008 | 5637 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2008 | 4078 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2006 | 5710 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 4113 | 0.010 |
Why?
|
| Mice | 2 | 2008 | 34495 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2008 | 7226 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 11538 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2009 | 7702 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2006 | 7222 | 0.010 |
Why?
|